Sarah Jerome, PhD, is currently the Regional MSL Director for Amyloidosis at AstraZeneca, where they lead the recruitment and training of a national MSL team in preparation for a product launch. Previously, they served as Regional MSL Director in Cardiovascular, Renal, and Metabolism at AstraZeneca from 2020 to 2023. Sarah also has extensive experience in the pharmaceutical industry, having worked with Genentech as a Senior Thought Leader Liaison in various therapeutic areas from 2005 to 2012, and as a Clinical Scientist at Centocor from 2001 to 2005. Earlier in their career, they were an Assistant Professor at the University of Central Arkansas from 1995 to 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices